Wang, Hongxia
Liang, Dongyu
Qian, Yu
Jiang, Yajun
Yang, Rong
Yin, Hong
Funding for this research was provided by:
Suzhou 2023 annual science and technology development plan, Suzhou (SKY2023152)
Natural Science Research Project of Jiading Distric (JDKW-2025-0024)
Article History
Received: 17 June 2025
Accepted: 27 September 2025
First Online: 25 November 2025
Declarations
:
: The authors declare no conflicts of interest.
: This study was approved by the Ethics Committee of Jiading District Central Hospital (No. RA-2023–348). Pathological diagnosis was reviewed according to the 2017 WHO classification of hematopoietic and lymphoid tumors. These tumor specimens archived in the pathology department are retrospective cases and are considered discarded specimens with informed consent exemption.
: The animal experiment protocol was carried out in accordance with the Guidelines for Animal Care and Use and was reviewed by the Laboratory Animal Welfare and Ethics Committee (IACUC Committee) of Saiye (Suzhou) Biotechnology Co., Ltd., and met the requirements of laboratory animal welfare and ethics (No. TACU23-FY028). All animal experiments were strictly implemented in compliance with the NIH Guide for the Care and Use of Laboratory Animals.